• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Deep Genomic Profiling in Breast Cancer Promises to Improve Outcomes

0
  • by alexperjescuadmin
  • in Oncology · Video
  • — 26 Mar, 2015

VIENNA—With actionable genomic alterations already being targeted by some existing approved drugs in patients with breast cancer genomic analysis was being hailed at the St Gallen Breast Cancer Conference as a way to expand the range of individualized cancer drugs by revealing more pathways responsible for breast cancer response and outcome. Farbice André MD, PhD, from the Institut Gustave Roussy in Villejuif, France, discussed the scope for bridging the gap between new genomic technologies and their application in the real world with Oncology Times reporter Sarah Maxwell.

Share

You may also like...

  • Daniel W. Lee Chimeric antigen receptor T-cell therapy rescues kids with relapsing acute lymphoblastic leukaemia 6 Aug, 2013
  • “Total Therapy” Possible Cure For Multiple Myeloma? “Total Therapy” Possible Cure For Multiple Myeloma? 26 Feb, 2008
  • Chronic Myeloid Leukemia 'To Become A Very Indolent Disease': Pregnancy Possible, Transplants Avoided—Mission Accomplished? Chronic Myeloid Leukemia ‘To Become A Very Indolent Disease’: Pregnancy Possible, Transplants Avoided—Mission Accomplished? 21 Apr, 2009
  • Dr Chi Eziefula World Malaria Day 2012: Dr Chi Eziefula, LSHTM: Old Drug New Hopes 24 Apr, 2012
  • Previous story Endocrine Therapy in Premenopausal Breast Cancer: Most Effective Not Always Best
  • Next story International Research and Consensus Needed to Interpret Breast Cancer Genomics Data
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Genomically Targeted Therapy Delays Advanced Breast…
    • Microbiome Diversity Key To Survival After…
    • ALK—Targeted Lung Cancer Drugs Benefited Real…
    • Pembrolizumab: No Survival Gains Second Line In…
  • Home
  • Oncology
  • Deep Genomic Profiling in Breast Cancer Promises to Improve Outcomes

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.